News
SGIOY
9.69
-4.15%
-0.42
Weekly Report: what happened at SGIOY last week (0413-0417)?
Weekly Report · 2d ago
Weekly Report: what happened at SGIOY last week (0406-0410)?
Weekly Report · 04/13 09:50
Centessa is the top performing foreign healthcare stock YTD
Seeking Alpha · 04/08 21:43
Weekly Report: what happened at SGIOY last week (0330-0403)?
Weekly Report · 04/06 09:50
Weekly Report: what happened at SGIOY last week (0323-0327)?
Weekly Report · 03/30 09:50
Weekly Report: what happened at SGIOY last week (0316-0320)?
Weekly Report · 03/23 09:48
Weekly Report: what happened at SGIOY last week (0309-0313)?
Weekly Report · 03/16 09:47
Weekly Report: what happened at SGIOY last week (0302-0306)?
Weekly Report · 03/09 09:49
Weekly Report: what happened at SGIOY last week (0223-0227)?
Weekly Report · 03/02 09:48
ViiV says early-stage data on VH184 for HIV could support twice-yearly dosing
Seeking Alpha · 02/25 20:50
Weekly Report: what happened at SGIOY last week (0216-0220)?
Weekly Report · 02/23 09:48
Weekly Report: what happened at SGIOY last week (0209-0213)?
Weekly Report · 02/16 09:47
Weekly Report: what happened at SGIOY last week (0202-0206)?
Weekly Report · 02/09 09:49
Shionogi & Co. GAAP EPS of ¥188.00, revenue of ¥500B
Seeking Alpha · 02/02 12:31
Weekly Report: what happened at SGIOY last week (0126-0130)?
Weekly Report · 02/02 09:48
Weekly Report: what happened at SGIOY last week (0119-0123)?
Weekly Report · 01/26 09:48
Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake
Seeking Alpha · 01/20 18:30
Weekly Report: what happened at SGIOY last week (0112-0116)?
Weekly Report · 01/19 09:52
Weekly Report: what happened at SGIOY last week (0105-0109)?
Weekly Report · 01/12 09:51
Weekly Report: what happened at SGIOY last week (1229-0102)?
Weekly Report · 01/05 09:48
More
Webull provides a variety of real-time SGIOY stock news. You can receive the latest news about Shionogi & Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SGIOY
Shionogi & Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the research and development, purchasing, manufacturing, sales, and related activities of ethical pharmaceuticals. The Company is engaged in research and development, purchasing, manufacturing, and marketing of pharmaceuticals for the treatment of gram-negative bacterial infections, influenza virus infections, new coronavirus infections, invasive aspergillus infections, complicated urinary tract infections including pyelonephritis, Alzheimer's disease, chronic pain, cancer of the esophagus, bladder, head and neck, solid tumors, and other diseases. The Company provides products and services in Japan, Europe, North America, and other regions.